Pathogenic Germline Variants Identified in Patients With Lun

A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable.

Related Keywords

Winston Salem , North Carolina , United States , American , Steven Sorscher , American Society For Clinical Oncology Plenary Series , Wake Forest School Of Medicine , Healthday News , American Society , Clinical Oncology Plenary , Wake Forest School ,